Type I Interferons As a Serum Biomarker Of Subclinical Atherosclerosis In Pediatric Systemic Lupus Erythematosus Patients.

被引：0
|
作者：
Mohan, Smriti [1 ]
Barsalou, Julie [2 ]
Bradley, Timothy J. [2 ]
Slorach, Cameron [2 ]
Ng, Lawrence [3 ]
Levy, Deborah M. [3 ,4 ]
Silverman, Earl D. [2 ]
Kaplan, Mariana J. [5 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[3] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[4] Univ Toronto, Toronto, ON, Canada
[5] Univ Michigan Rheumatol, Ann Arbor, MI USA
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1615
引用
收藏
页码：S686 / S686
页数：1
相关论文
共 50 条
  • [1] Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients
    Somers, Emily C.
    Zhao, Wenpu
    Lewis, Emily E.
    Wang, Lu
    Wing, Jeffrey J.
    Sundaram, Baskaran
    Kazerooni, Ella A.
    McCune, W. Joseph
    Kaplan, Mariana J.
    PLOS ONE, 2012, 7 (05):
  • [2] Serum osteoprotegrin (OPG) in subclinical atherosclerosis in systemic lupus erythematosus
    Kiani, A. N.
    Aukrust, P.
    Ueland, T.
    Hollan, I.
    Barr, E.
    Magder, L. S.
    Petri, M.
    LUPUS, 2017, 26 (08) : 865 - 870
  • [3] Type-I interferons and systemic lupus erythematosus
    Koutouzov, Sophie
    Mathian, Alexis
    Dalloul, Ali
    AUTOIMMUNITY REVIEWS, 2006, 5 (08) : 554 - 562
  • [4] Subclinical atherosclerosis in systemic lupus erythematosus
    Mercado, U
    Avendaño, L
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (06) : 1171 - 1172
  • [5] Subclinical atherosclerosis in systemic lupus erythematosus
    Ahmad, Y
    Bruce, IN
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (05) : 841 - 843
  • [6] Serum Metabolomic Signatures Can Predict Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus
    Coelewij, Leda
    Waddington, Kirsty E.
    Robinson, George A.
    Chocano, Elvira
    McDonnell, Thomas
    Farinha, Filipa
    Peng, Junjie
    Donnes, Pierre
    Smith, Edward
    Croca, Sara
    Bakshi, Jyoti
    Griffin, Maura
    Nicolaides, Andrew
    Rahman, Anisur
    Jury, Elizabeth C.
    Pineda-Torra, Ines
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (04) : 1446 - 1458
  • [7] Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus
    Icli, Abdullah
    Cure, Erkan
    Cure, Medine Cumhur
    Uslu, Ali Ugur
    Balta, Sevket
    Mikhailidis, Dimitri P.
    Ozturk, Cengiz
    Arslan, Sevket
    Sakiz, Davut
    Sahin, Muhammed
    Kucuk, Adem
    ANGIOLOGY, 2016, 67 (08) : 749 - 755
  • [8] SERUM LEVELS OF INTERFERONS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    KIM, T
    KANAYAMA, Y
    NEGORO, N
    OKAMURA, M
    TAKEDA, T
    INOUE, T
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1987, 70 (03): : 562 - 569
  • [9] PARATHORMONE BUT NOT VITAMIN D SERUM LEVELS ARE ASSOCIATED WITH SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Giannelou, Mayra
    Stamouli, Aikaterini
    Antypa, Eleni
    Moutsopoulos, Haralampos M.
    Mavragani, Clio
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1720 - 1720
  • [10] Systemic lupus erythematosus: all roads lead to type I interferons
    Pascual, Virginia
    Farkas, Lorant
    Banchereau, Jacques
    CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (06) : 676 - 682
12345